Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow‐derived mesenchymal stem cells

MSCs (mesenchymal stem cells) with their versatile growth and differentiation potential are ideal candidates for use in regenerative medicine and are currently making their way into clinical trials, which requires the development of xeno‐free protocols for their culture. In this study, MSCs were cultured in 10% FCS or 7.5% HPL (human platelet lysate)‐supplemented media. We found that both groups of MSCs showed a comparable morphology, phenotype and proliferation. The percentage of cells in the S‐ and G2‐/M‐phases, however, was slightly up‐regulated (P<0.01) in HPL group. HPL contains PDGF (platelet derived growth factor)‐AB and IGF (insulin‐like growth factor)‐1. In addition, compared with FCS group, MSCs in HPL group showed an increase in osteogenic differentiation and a decrease in adipogenic differentiation. In conclusion, MSCs in HPL‐supplemented media maintained similar growing potential and phenotype, while osteogenic potential was enhanced. HPL offers a promising alternative to FCS for MSC expansion for clinical application, especially in bone injury diseases.

[1]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[2]  X. Holy,et al.  Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications , 2005, Journal of cellular physiology.

[3]  C. Choong,et al.  PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. , 2008, Blood.

[4]  B. Lahn,et al.  Proteomic identification of differently expressed proteins responsible for osteoblast differentiation from human mesenchymal stem cells , 2007, Molecular and Cellular Biochemistry.

[5]  J. Wiltfang,et al.  Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates , 2003, Vox sanguinis.

[6]  R. Handgretinger,et al.  Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. , 2006, Cytotherapy.

[7]  Jinkuk Kim,et al.  The role of mesenchymal stem cells in the functional improvement of chronic renal failure. , 2009, Stem cells and development.

[8]  J. Domenech,et al.  Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients. , 2009, Cytotherapy.

[9]  David L. Kaplan,et al.  Membrane Potential Controls Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells , 2008, PloS one.

[10]  R. Cancedda,et al.  Osteogenic Differentiation of Human Mesenchymal Stromal Cells on Surface-Modified Titanium Alloys for Orthopedic and Dental Implants , 2009, The International journal of artificial organs.

[11]  A. Cometa,et al.  Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substitute , 2007, Journal of cellular physiology.

[12]  M. Dezawa.  Systematic neuronal and muscle induction systems in bone marrow stromal cells: the potential for tissue reconstruction in neurodegenerative and muscle degenerative diseases , 2008, Medical Molecular Morphology.

[13]  W. Richter,et al.  Mesenchymal stem cells and cartilage in situ regeneration , 2009, Journal of internal medicine.

[14]  M. Shokrgozar,et al.  Effects of cyclic stretch on proliferation of mesenchymal stem cells and their differentiation to smooth muscle cells. , 2009, Biochemical and biophysical research communications.

[15]  S. Koelling,et al.  Stem cell therapy for cartilage regeneration in osteoarthritis , 2009, Expert opinion on biological therapy.

[16]  M. Waters,et al.  Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. , 2003, Molecular endocrinology.

[17]  Y. Ishii,et al.  PDGF Receptor β Is a Potent Regulator of Mesenchymal Stromal Cell Function , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  G. Mazziotti,et al.  Growth hormone, insulin-like growth factors, and the skeleton. , 2008, Endocrine reviews.

[19]  E. Schipani,et al.  Bone marrow mesenchymal stem cells , 2009, Journal of cellular biochemistry.

[20]  M. Chopp,et al.  Marrow Stromal Cell Transplantation in Stroke and Traumatic Brain Injury Nih Public Access Author Manuscript , 2022 .

[21]  D. Strunk,et al.  Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow , 2009, Stem cells.

[22]  Karl Kashofer,et al.  Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells , 2007, Transfusion.